A Review of Clinical Poster Presentations at the Sixth Biennial Pediatric Anesthesia Neurodevelopment Assessment (PANDA) Symposium

Manon Haché, Tom G. Hansen, Ruth Graham, Jamie W. Sinton, Phillip S. Adams, Carol Garber, Lynne Maxwell, Teeda Pinyavat*

*Kontaktforfatter for dette arbejde

Publikation: Bidrag til tidsskriftReviewForskningpeer review

Resumé

Clinical researchers studying the long-term neurocognitive effects of anesthetic and sedative agents on children continue to struggle with identifying a phenotype for anesthetic neurotoxicity, the window of vulnerability, and the toxicity threshold in terms of concentration and duration. The Sixth Biennial Pediatric Anesthesia Neurodevelopment Assessment (PANDA) symposium at Columbia University included a moderated poster presentation session where 4 investigators presented their latest contributions to the landscape of clinical anesthetic neurotoxicity research. A lack of standardization in the design of clinical studies in terms of age at exposure, duration and type of exposure, and outcome measures assessed were highlighted by all the investigators. Suggestions for the future direction of clinical trials included the implementation of more consistent study parameters and the employment of standardized neurocognitive testing and imaging before and after exposure to general anesthesia. Presentations covered a broad range of topics including the valid translation of preclinical studies to human subjects, the quantification of real-world exposures to anesthetic and sedative medications, and possible alternatives to these exposures.

OriginalsprogEngelsk
TidsskriftJournal of Neurosurgical Anesthesiology
Vol/bind31
Udgave nummer1
Sider (fra-til)166-169
ISSN0898-4921
DOI
StatusUdgivet - 1. jan. 2019

Fingeraftryk

Posters
Pediatrics
Research Personnel
Hypnotics and Sedatives
Outcome Assessment (Health Care)
Clinical Trials
Research

Citer dette

Haché, Manon ; Hansen, Tom G. ; Graham, Ruth ; Sinton, Jamie W. ; Adams, Phillip S. ; Garber, Carol ; Maxwell, Lynne ; Pinyavat, Teeda. / A Review of Clinical Poster Presentations at the Sixth Biennial Pediatric Anesthesia Neurodevelopment Assessment (PANDA) Symposium. I: Journal of Neurosurgical Anesthesiology. 2019 ; Bind 31, Nr. 1. s. 166-169.
@article{722672894db549e7995ebe4d3a4e0a19,
title = "A Review of Clinical Poster Presentations at the Sixth Biennial Pediatric Anesthesia Neurodevelopment Assessment (PANDA) Symposium",
abstract = "Clinical researchers studying the long-term neurocognitive effects of anesthetic and sedative agents on children continue to struggle with identifying a phenotype for anesthetic neurotoxicity, the window of vulnerability, and the toxicity threshold in terms of concentration and duration. The Sixth Biennial Pediatric Anesthesia Neurodevelopment Assessment (PANDA) symposium at Columbia University included a moderated poster presentation session where 4 investigators presented their latest contributions to the landscape of clinical anesthetic neurotoxicity research. A lack of standardization in the design of clinical studies in terms of age at exposure, duration and type of exposure, and outcome measures assessed were highlighted by all the investigators. Suggestions for the future direction of clinical trials included the implementation of more consistent study parameters and the employment of standardized neurocognitive testing and imaging before and after exposure to general anesthesia. Presentations covered a broad range of topics including the valid translation of preclinical studies to human subjects, the quantification of real-world exposures to anesthetic and sedative medications, and possible alternatives to these exposures.",
keywords = "anesthesia, clinical research, neurodevelopment, neurotoxicity, outcomes, pediatric, surgery, Anesthesia/adverse effects, Anesthetics/adverse effects, Humans, Developmental Disabilities/chemically induced, Child, Preschool, Infant, Animals, Adolescent, Neurotoxicity Syndromes, Anesthesiology, Child, Infant, Newborn",
author = "Manon Hach{\'e} and Hansen, {Tom G.} and Ruth Graham and Sinton, {Jamie W.} and Adams, {Phillip S.} and Carol Garber and Lynne Maxwell and Teeda Pinyavat",
year = "2019",
month = "1",
day = "1",
doi = "10.1097/ANA.0000000000000543",
language = "English",
volume = "31",
pages = "166--169",
journal = "Journal of Neurosurgical Anesthesiology",
issn = "0898-4921",
publisher = "Lippincott Williams & Wilkins",
number = "1",

}

A Review of Clinical Poster Presentations at the Sixth Biennial Pediatric Anesthesia Neurodevelopment Assessment (PANDA) Symposium. / Haché, Manon; Hansen, Tom G.; Graham, Ruth; Sinton, Jamie W.; Adams, Phillip S.; Garber, Carol; Maxwell, Lynne; Pinyavat, Teeda.

I: Journal of Neurosurgical Anesthesiology, Bind 31, Nr. 1, 01.01.2019, s. 166-169.

Publikation: Bidrag til tidsskriftReviewForskningpeer review

TY - JOUR

T1 - A Review of Clinical Poster Presentations at the Sixth Biennial Pediatric Anesthesia Neurodevelopment Assessment (PANDA) Symposium

AU - Haché, Manon

AU - Hansen, Tom G.

AU - Graham, Ruth

AU - Sinton, Jamie W.

AU - Adams, Phillip S.

AU - Garber, Carol

AU - Maxwell, Lynne

AU - Pinyavat, Teeda

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Clinical researchers studying the long-term neurocognitive effects of anesthetic and sedative agents on children continue to struggle with identifying a phenotype for anesthetic neurotoxicity, the window of vulnerability, and the toxicity threshold in terms of concentration and duration. The Sixth Biennial Pediatric Anesthesia Neurodevelopment Assessment (PANDA) symposium at Columbia University included a moderated poster presentation session where 4 investigators presented their latest contributions to the landscape of clinical anesthetic neurotoxicity research. A lack of standardization in the design of clinical studies in terms of age at exposure, duration and type of exposure, and outcome measures assessed were highlighted by all the investigators. Suggestions for the future direction of clinical trials included the implementation of more consistent study parameters and the employment of standardized neurocognitive testing and imaging before and after exposure to general anesthesia. Presentations covered a broad range of topics including the valid translation of preclinical studies to human subjects, the quantification of real-world exposures to anesthetic and sedative medications, and possible alternatives to these exposures.

AB - Clinical researchers studying the long-term neurocognitive effects of anesthetic and sedative agents on children continue to struggle with identifying a phenotype for anesthetic neurotoxicity, the window of vulnerability, and the toxicity threshold in terms of concentration and duration. The Sixth Biennial Pediatric Anesthesia Neurodevelopment Assessment (PANDA) symposium at Columbia University included a moderated poster presentation session where 4 investigators presented their latest contributions to the landscape of clinical anesthetic neurotoxicity research. A lack of standardization in the design of clinical studies in terms of age at exposure, duration and type of exposure, and outcome measures assessed were highlighted by all the investigators. Suggestions for the future direction of clinical trials included the implementation of more consistent study parameters and the employment of standardized neurocognitive testing and imaging before and after exposure to general anesthesia. Presentations covered a broad range of topics including the valid translation of preclinical studies to human subjects, the quantification of real-world exposures to anesthetic and sedative medications, and possible alternatives to these exposures.

KW - anesthesia

KW - clinical research

KW - neurodevelopment

KW - neurotoxicity

KW - outcomes

KW - pediatric

KW - surgery

KW - Anesthesia/adverse effects

KW - Anesthetics/adverse effects

KW - Humans

KW - Developmental Disabilities/chemically induced

KW - Child, Preschool

KW - Infant

KW - Animals

KW - Adolescent

KW - Neurotoxicity Syndromes

KW - Anesthesiology

KW - Child

KW - Infant, Newborn

U2 - 10.1097/ANA.0000000000000543

DO - 10.1097/ANA.0000000000000543

M3 - Review

VL - 31

SP - 166

EP - 169

JO - Journal of Neurosurgical Anesthesiology

JF - Journal of Neurosurgical Anesthesiology

SN - 0898-4921

IS - 1

ER -